| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E SLC22A6 TRPM8 SLC35A3 SLC44A1 PIEZO2 SLC16A14 PIEZO1 SLC35B3 | 2.90e-11 | 1180 | 26 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E SLC22A6 TRPM8 SLC35A3 SLC44A1 PIEZO2 SLC16A14 PIEZO1 SLC35B3 | 9.44e-11 | 1289 | 26 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 PIEZO2 PIEZO1 | 2.24e-10 | 334 | 26 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 PIEZO2 PIEZO1 | 3.66e-09 | 459 | 26 | 9 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 PIEZO2 PIEZO1 | 1.18e-08 | 525 | 26 | 9 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 PIEZO2 PIEZO1 | 1.20e-08 | 526 | 26 | 9 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.64e-07 | 9 | 26 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.64e-07 | 9 | 26 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 PIEZO2 PIEZO1 | 3.99e-07 | 793 | 26 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 7.07e-07 | 14 | 26 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.58e-06 | 18 | 26 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.87e-06 | 19 | 26 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.97e-06 | 22 | 26 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.53e-06 | 758 | 26 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 GABRE GABRG1 CCR3 ADRA2A C5AR1 MCHR1 OR52A4P CRHR2 AGTR1 | 3.84e-06 | 1353 | 26 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.24e-06 | 343 | 26 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.10e-05 | 884 | 26 | 8 | GO:0004930 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.23e-05 | 129 | 26 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.87e-05 | 46 | 26 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.90e-05 | 138 | 26 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.53e-05 | 296 | 26 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.69e-05 | 50 | 26 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.13e-05 | 151 | 26 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 6.70e-05 | 171 | 26 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.11e-05 | 65 | 26 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.11e-05 | 65 | 26 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 8.90e-05 | 11 | 26 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.07e-04 | 193 | 26 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.16e-04 | 197 | 26 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.34e-04 | 77 | 26 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.72e-04 | 664 | 26 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.87e-04 | 86 | 26 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.46e-04 | 18 | 26 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.91e-04 | 100 | 26 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 3.05e-04 | 20 | 26 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | hormone binding | 3.18e-04 | 103 | 26 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.18e-04 | 103 | 26 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.31e-04 | 477 | 26 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.26e-04 | 293 | 26 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.60e-04 | 125 | 26 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.71e-04 | 133 | 26 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 7.79e-04 | 140 | 26 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.70e-04 | 151 | 26 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 9.89e-04 | 152 | 26 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.66e-03 | 182 | 26 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.71e-03 | 184 | 26 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.49e-03 | 57 | 26 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.67e-03 | 59 | 26 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.67e-03 | 59 | 26 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.75e-03 | 60 | 26 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.89e-03 | 465 | 26 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.27e-03 | 75 | 26 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | amide binding | 6.70e-03 | 299 | 26 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 7.75e-03 | 102 | 26 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | peptide binding | 7.93e-03 | 318 | 26 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.31e-03 | 627 | 26 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.94e-02 | 165 | 26 | 2 | GO:0140375 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E SLC22A6 TRPM8 ADRA2A PIEZO2 MCHR1 CRHR2 PIEZO1 AGTR1 | 1.44e-10 | 1374 | 26 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 ADRA2A PIEZO2 PIEZO1 AGTR1 | 4.00e-08 | 1115 | 26 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.01e-07 | 35 | 26 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | calcium ion import | 1.33e-07 | 98 | 26 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.38e-07 | 509 | 26 | 8 | GO:0006816 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.72e-07 | 48 | 26 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.72e-07 | 48 | 26 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B CACNA1E TRPM8 ADRA2A PIEZO2 MCHR1 CRHR2 PIEZO1 AGTR1 | 6.90e-07 | 1157 | 26 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E TRPM8 ADRA2A AGTR1 | 2.43e-06 | 1017 | 26 | 9 | GO:0098660 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 7.57e-06 | 392 | 26 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 7.89e-06 | 224 | 26 | 5 | GO:0007204 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.26e-05 | 931 | 26 | 8 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.26e-05 | 931 | 26 | 8 | GO:0007268 | |
| GeneOntologyBiologicalProcess | excretion | 1.34e-05 | 37 | 26 | 3 | GO:0007588 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.34e-05 | 939 | 26 | 8 | GO:0099537 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.38e-05 | 942 | 26 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.78e-05 | 976 | 26 | 8 | GO:0099536 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.79e-05 | 126 | 26 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | metal ion transport | 2.12e-05 | 1000 | 26 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | amine transport | 2.49e-05 | 137 | 26 | 4 | GO:0015837 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.86e-05 | 142 | 26 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.86e-05 | 142 | 26 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | organic cation transport | 3.11e-05 | 145 | 26 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | response to pain | 3.56e-05 | 51 | 26 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 4.58e-05 | 323 | 26 | 5 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 4.79e-05 | 326 | 26 | 5 | GO:1903522 | |
| GeneOntologyBiologicalProcess | thermoception | 5.47e-05 | 9 | 26 | 2 | GO:0050955 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.59e-05 | 559 | 26 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 6.67e-05 | 577 | 26 | 6 | GO:0043269 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 6.83e-05 | 10 | 26 | 2 | GO:0032811 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 7.22e-05 | 180 | 26 | 4 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 7.69e-05 | 183 | 26 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | negative regulation of norepinephrine secretion | 8.35e-05 | 11 | 26 | 2 | GO:0010700 | |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 8.35e-05 | 11 | 26 | 2 | GO:0014060 | |
| GeneOntologyBiologicalProcess | behavior | 8.76e-05 | 891 | 26 | 7 | GO:0007610 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.09e-04 | 74 | 26 | 3 | GO:0051932 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 1.18e-04 | 13 | 26 | 2 | GO:0048242 | |
| GeneOntologyBiologicalProcess | regulation of excretion | 1.18e-04 | 13 | 26 | 2 | GO:0044062 | |
| GeneOntologyBiologicalProcess | signal release | 1.32e-04 | 653 | 26 | 6 | GO:0023061 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.49e-04 | 217 | 26 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.86e-04 | 230 | 26 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | epinephrine transport | 2.05e-04 | 17 | 26 | 2 | GO:0048241 | |
| GeneOntologyBiologicalProcess | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 2.05e-04 | 17 | 26 | 2 | GO:0061179 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 2.07e-04 | 92 | 26 | 3 | GO:0061178 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.23e-04 | 1395 | 26 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | circulatory system process | 2.47e-04 | 733 | 26 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.60e-04 | 740 | 26 | 6 | GO:1903530 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 2.81e-04 | 102 | 26 | 3 | GO:0035773 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 3.23e-04 | 266 | 26 | 4 | GO:0043270 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 3.32e-04 | 493 | 26 | 5 | GO:0010959 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.70e-04 | 112 | 26 | 3 | GO:1902476 | |
| GeneOntologyBiologicalProcess | renal tubular secretion | 3.80e-04 | 23 | 26 | 2 | GO:0097254 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 3.80e-04 | 23 | 26 | 2 | GO:0033604 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 3.98e-04 | 801 | 26 | 6 | GO:0051046 | |
| GeneOntologyBiologicalProcess | organic anion transport | 4.05e-04 | 515 | 26 | 5 | GO:0015711 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4.25e-04 | 286 | 26 | 4 | GO:0007188 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 4.31e-04 | 118 | 26 | 3 | GO:0046928 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 4.54e-04 | 291 | 26 | 4 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 4.87e-04 | 26 | 26 | 2 | GO:0014061 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 5.10e-04 | 125 | 26 | 3 | GO:0016079 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 5.10e-04 | 125 | 26 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | chloride transport | 5.47e-04 | 128 | 26 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 5.66e-04 | 28 | 26 | 2 | GO:0048243 | |
| GeneOntologyBiologicalProcess | catechol-containing compound biosynthetic process | 6.07e-04 | 29 | 26 | 2 | GO:0009713 | |
| GeneOntologyBiologicalProcess | catecholamine biosynthetic process | 6.07e-04 | 29 | 26 | 2 | GO:0042423 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.11e-04 | 133 | 26 | 3 | GO:0007200 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 6.25e-04 | 134 | 26 | 3 | GO:0098661 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 6.50e-04 | 30 | 26 | 2 | GO:1904862 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 7.25e-04 | 141 | 26 | 3 | GO:0051588 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.40e-04 | 32 | 26 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 7.96e-04 | 338 | 26 | 4 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 8.05e-04 | 339 | 26 | 4 | GO:0033500 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 8.34e-04 | 148 | 26 | 3 | GO:0009308 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 8.37e-04 | 922 | 26 | 6 | GO:0098662 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 9.18e-04 | 153 | 26 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 9.56e-04 | 355 | 26 | 4 | GO:0046883 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 9.86e-04 | 358 | 26 | 4 | GO:0015850 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.04e-03 | 38 | 26 | 2 | GO:0050951 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 1.04e-03 | 38 | 26 | 2 | GO:0015874 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.08e-03 | 162 | 26 | 3 | GO:0007631 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 1.14e-03 | 165 | 26 | 3 | GO:1903305 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.15e-03 | 648 | 26 | 5 | GO:0008015 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 1.27e-03 | 171 | 26 | 3 | GO:0043271 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.27e-03 | 663 | 26 | 5 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.28e-03 | 664 | 26 | 5 | GO:0099177 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 1.34e-03 | 43 | 26 | 2 | GO:0051953 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.46e-03 | 684 | 26 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 1.46e-03 | 45 | 26 | 2 | GO:0017158 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.47e-03 | 180 | 26 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | biogenic amine biosynthetic process | 1.60e-03 | 47 | 26 | 2 | GO:0042401 | |
| GeneOntologyBiologicalProcess | amine biosynthetic process | 1.66e-03 | 48 | 26 | 2 | GO:0009309 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.76e-03 | 1064 | 26 | 6 | GO:0032940 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 1.78e-03 | 420 | 26 | 4 | GO:0045765 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.78e-03 | 420 | 26 | 4 | GO:0046879 | |
| GeneOntologyBiologicalProcess | sensory perception | 1.82e-03 | 1072 | 26 | 6 | GO:0007600 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.84e-03 | 195 | 26 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.84e-03 | 195 | 26 | 3 | GO:0007269 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.63e-06 | 19 | 26 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 2.24e-06 | 21 | 26 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.70e-06 | 378 | 26 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 8.45e-06 | 405 | 26 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E ADRA2A CRHR2 AGTR1 | 1.02e-05 | 1228 | 26 | 9 | GO:0036477 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.50e-05 | 46 | 26 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.64e-05 | 141 | 26 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.58e-05 | 523 | 26 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 4.74e-05 | 550 | 26 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.77e-05 | 164 | 26 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.78e-05 | 57 | 26 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | dendrite | 6.35e-05 | 858 | 26 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.45e-05 | 860 | 26 | 7 | GO:0097447 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.56e-05 | 583 | 26 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.00e-04 | 73 | 26 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.22e-04 | 78 | 26 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.58e-04 | 277 | 26 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 6.17e-04 | 320 | 26 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | presynapse | 6.33e-04 | 886 | 26 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | basal plasma membrane | 9.00e-04 | 354 | 26 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.15e-03 | 378 | 26 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | postsynapse | 1.31e-03 | 1018 | 26 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.86e-03 | 431 | 26 | 4 | GO:0031253 | |
| GeneOntologyCellularComponent | axon terminus | 2.19e-03 | 210 | 26 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.19e-03 | 210 | 26 | 3 | GO:0031256 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.20e-03 | 56 | 26 | 2 | GO:0032590 | |
| GeneOntologyCellularComponent | perikaryon | 2.60e-03 | 223 | 26 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron projection terminus | 2.94e-03 | 233 | 26 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | cation channel complex | 3.01e-03 | 235 | 26 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.28e-03 | 835 | 26 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | neuron projection membrane | 4.65e-03 | 82 | 26 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | cell body | 5.18e-03 | 929 | 26 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | receptor complex | 5.43e-03 | 581 | 26 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | membrane protein complex | 8.89e-03 | 1498 | 26 | 6 | GO:0098796 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.58e-02 | 155 | 26 | 2 | GO:0098685 | |
| GeneOntologyCellularComponent | distal axon | 1.63e-02 | 435 | 26 | 3 | GO:0150034 | |
| MousePheno | abnormal channel response | 1.55e-05 | 33 | 21 | 3 | MP:0003484 | |
| MousePheno | increased heart rate | 2.76e-05 | 120 | 21 | 4 | MP:0002626 | |
| MousePheno | abnormal heart rate | 3.63e-05 | 445 | 21 | 6 | MP:0001629 | |
| MousePheno | abnormal heartbeat | 7.05e-05 | 501 | 21 | 6 | MP:0004085 | |
| MousePheno | abnormal behavioral response to xenobiotic | 7.77e-05 | 309 | 21 | 5 | MP:0009745 | |
| MousePheno | abnormal drinking behavior | 8.29e-05 | 159 | 21 | 4 | MP:0001422 | |
| MousePheno | abnormal hormone level | 9.66e-05 | 1073 | 21 | 8 | MP:0003953 | |
| MousePheno | enhanced behavioral response to xenobiotic | 1.44e-04 | 69 | 21 | 3 | MP:0009746 | |
| MousePheno | impaired behavioral response to xenobiotic | 2.49e-04 | 83 | 21 | 3 | MP:0009747 | |
| MousePheno | enhanced behavioral response to alcohol | 2.55e-04 | 16 | 21 | 2 | MP:0009751 | |
| MousePheno | abnormal frequency of paradoxical sleep | 3.62e-04 | 19 | 21 | 2 | MP:0003194 | |
| MousePheno | decreased circulating glucagon level | 4.02e-04 | 20 | 21 | 2 | MP:0002696 | |
| MousePheno | abnormal systemic arterial blood pressure | 4.36e-04 | 245 | 21 | 4 | MP:0000230 | |
| MousePheno | abnormal paradoxical sleep pattern | 5.34e-04 | 23 | 21 | 2 | MP:0012288 | |
| MousePheno | abnormal spike wave discharge | 5.82e-04 | 24 | 21 | 2 | MP:0008840 | |
| MousePheno | abnormal behavioral response to alcohol | 5.82e-04 | 24 | 21 | 2 | MP:0020157 | |
| MousePheno | abnormal pain threshold | 6.03e-04 | 267 | 21 | 4 | MP:0001970 | |
| MousePheno | abnormal synaptic transmission | 6.75e-04 | 1070 | 21 | 7 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 6.98e-04 | 1076 | 21 | 7 | MP:0021009 | |
| MousePheno | abnormal liquid preference | 9.74e-04 | 31 | 21 | 2 | MP:0001423 | |
| MousePheno | abnormal fluid intake | 1.05e-03 | 136 | 21 | 3 | MP:0011947 | |
| MousePheno | abnormal alcohol consumption | 1.24e-03 | 35 | 21 | 2 | MP:0001425 | |
| MousePheno | abnormal single cell response | 1.24e-03 | 35 | 21 | 2 | MP:0003463 | |
| MousePheno | absence seizures | 1.24e-03 | 35 | 21 | 2 | MP:0003216 | |
| MousePheno | abnormal nervous system electrophysiology | 1.31e-03 | 329 | 21 | 4 | MP:0002272 | |
| MousePheno | nonconvulsive seizures | 1.62e-03 | 40 | 21 | 2 | MP:0000948 | |
| MousePheno | abnormal circulating glucagon level | 1.62e-03 | 40 | 21 | 2 | MP:0002695 | |
| MousePheno | increased systemic arterial blood pressure | 1.62e-03 | 158 | 21 | 3 | MP:0002842 | |
| MousePheno | abnormal thermal nociception | 1.93e-03 | 168 | 21 | 3 | MP:0002733 | |
| MousePheno | enhanced behavioral response to addictive substance | 1.96e-03 | 44 | 21 | 2 | MP:0009749 | |
| MousePheno | hypoalgesia | 2.00e-03 | 170 | 21 | 3 | MP:0003043 | |
| MousePheno | hyporesponsive to tactile stimuli | 2.05e-03 | 45 | 21 | 2 | MP:0005498 | |
| MousePheno | decreased hormone level | 2.11e-03 | 635 | 21 | 5 | MP:0014455 | |
| MousePheno | abnormal touch/ nociception | 2.14e-03 | 376 | 21 | 4 | MP:0001968 | |
| Domain | Ca_chan_IQ | 8.35e-08 | 7 | 26 | 3 | PF08763 | |
| Domain | GPHH | 8.35e-08 | 7 | 26 | 3 | PF16905 | |
| Domain | GPHH_dom | 8.35e-08 | 7 | 26 | 3 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 8.35e-08 | 7 | 26 | 3 | IPR014873 | |
| Domain | Ca_chan_IQ | 8.35e-08 | 7 | 26 | 3 | SM01062 | |
| Domain | VDCCAlpha1 | 2.86e-07 | 10 | 26 | 3 | IPR002077 | |
| Domain | Piezo | 1.86e-06 | 2 | 26 | 2 | IPR027272 | |
| Domain | Piezo_dom | 1.86e-06 | 2 | 26 | 2 | IPR031805 | |
| Domain | Piezo_RRas_bdg | 1.86e-06 | 2 | 26 | 2 | PF12166 | |
| Domain | PIEZO | 1.86e-06 | 2 | 26 | 2 | PF15917 | |
| Domain | Piezo_RRas-bd_dom | 1.86e-06 | 2 | 26 | 2 | IPR031334 | |
| Domain | GABAA/Glycine_rcpt | 4.16e-06 | 23 | 26 | 3 | IPR006028 | |
| Domain | Ion_trans_dom | 1.77e-05 | 114 | 26 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.77e-05 | 114 | 26 | 4 | PF00520 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.27e-05 | 45 | 26 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 3.49e-05 | 46 | 26 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 3.73e-05 | 47 | 26 | 3 | PF02931 | |
| Domain | Neur_channel | 3.73e-05 | 47 | 26 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.73e-05 | 47 | 26 | 3 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 3.73e-05 | 47 | 26 | 3 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 3.73e-05 | 47 | 26 | 3 | PS00236 | |
| Domain | - | 3.73e-05 | 47 | 26 | 3 | 2.70.170.10 | |
| Domain | Channel_four-helix_dom | 6.67e-05 | 57 | 26 | 3 | IPR027359 | |
| Domain | - | 6.67e-05 | 57 | 26 | 3 | 1.20.120.350 | |
| Domain | GPCR_Rhodpsn_7TM | 2.59e-04 | 670 | 26 | 6 | IPR017452 | |
| Domain | 7tm_1 | 2.74e-04 | 677 | 26 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.92e-04 | 685 | 26 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.06e-04 | 691 | 26 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.09e-04 | 692 | 26 | 6 | IPR000276 | |
| Domain | MFS | 9.84e-03 | 108 | 26 | 2 | PS50850 | |
| Domain | 7TM_GPCR_Srsx | 1.05e-02 | 112 | 26 | 2 | SM01381 | |
| Domain | MFS_dom | 1.48e-02 | 134 | 26 | 2 | IPR020846 | |
| Domain | EF_HAND_2 | 4.07e-02 | 231 | 26 | 2 | PS50222 | |
| Domain | EF_hand_dom | 4.11e-02 | 232 | 26 | 2 | IPR002048 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.79e-09 | 272 | 20 | 8 | M13380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.00e-07 | 11 | 20 | 3 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.00e-07 | 11 | 20 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.00e-07 | 11 | 20 | 3 | M26913 | |
| Pathway | WP_GPCRS_NONODORANT | 1.32e-06 | 266 | 20 | 6 | MM15843 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.25e-06 | 23 | 20 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.51e-06 | 25 | 20 | 3 | M47948 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.07e-05 | 31 | 20 | 3 | M39369 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 2.00e-05 | 38 | 20 | 3 | M39854 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.10e-05 | 430 | 20 | 6 | MM15160 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.18e-05 | 463 | 20 | 6 | M507 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.81e-05 | 47 | 20 | 3 | M19708 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 6.84e-05 | 9 | 20 | 2 | MM15421 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 6.84e-05 | 9 | 20 | 2 | M27688 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 7.92e-05 | 330 | 20 | 5 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 8.26e-05 | 333 | 20 | 5 | MM14963 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 8.34e-05 | 61 | 20 | 3 | MM15071 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.02e-04 | 178 | 20 | 4 | M2890 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.20e-04 | 186 | 20 | 4 | MM15994 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.26e-04 | 70 | 20 | 3 | MM15959 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.37e-04 | 72 | 20 | 3 | MM14631 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.43e-04 | 73 | 20 | 3 | MM16641 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.50e-04 | 197 | 20 | 4 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.50e-04 | 197 | 20 | 4 | MM14970 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.55e-04 | 75 | 20 | 3 | M39696 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.74e-04 | 78 | 20 | 3 | M1921 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.96e-04 | 211 | 20 | 4 | MM14502 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.02e-04 | 646 | 20 | 6 | MM14962 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.10e-04 | 238 | 20 | 4 | MM15076 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.17e-04 | 702 | 20 | 6 | M746 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.68e-04 | 249 | 20 | 4 | M5988 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.34e-04 | 260 | 20 | 4 | M39397 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.53e-04 | 108 | 20 | 3 | M17034 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.01e-04 | 270 | 20 | 4 | M15514 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 6.02e-04 | 119 | 20 | 3 | M48309 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 6.47e-04 | 289 | 20 | 4 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 8.82e-04 | 314 | 20 | 4 | M600 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.11e-03 | 147 | 20 | 3 | MM15854 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.12e-03 | 335 | 20 | 4 | MM14503 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.20e-03 | 151 | 20 | 3 | M39329 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.52e-03 | 41 | 20 | 2 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.67e-03 | 43 | 20 | 2 | M881 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.19e-03 | 681 | 20 | 5 | MM14985 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 2.34e-03 | 51 | 20 | 2 | M39457 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.38e-03 | 411 | 20 | 4 | M735 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 2.43e-03 | 52 | 20 | 2 | M5785 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.08e-03 | 736 | 20 | 5 | M27287 | |
| Pathway | WP_MAPK_SIGNALING | 4.80e-03 | 246 | 20 | 3 | M39597 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.12e-03 | 76 | 20 | 2 | MM15072 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 6.03e-03 | 267 | 20 | 3 | M10792 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.22e-03 | 84 | 20 | 2 | M27334 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.44e-02 | 367 | 20 | 3 | M48346 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 3.71e-10 | 3 | 26 | 3 | 24523520 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.48e-09 | 4 | 26 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.48e-09 | 4 | 26 | 3 | 37141091 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 8825650 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 11296258 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 15451373 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 7.41e-09 | 6 | 26 | 3 | 35324301 | |
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 9238069 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 7.41e-09 | 6 | 26 | 3 | 12827191 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.30e-08 | 7 | 26 | 3 | 35176221 | |
| Pubmed | 3.11e-08 | 9 | 26 | 3 | 16382099 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 20188150 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 24453333 | ||
| Pubmed | 2.06e-07 | 179 | 26 | 5 | 18577758 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 38448588 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 2.23e-07 | 182 | 26 | 5 | 20468064 | |
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 19078961 | ||
| Pubmed | 3.57e-07 | 200 | 26 | 5 | 18240029 | ||
| Pubmed | 4.54e-07 | 405 | 26 | 6 | 38187761 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30324494 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 5.37e-07 | 2 | 26 | 2 | 23426690 | |
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 5.37e-07 | 2 | 26 | 2 | 21299953 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20110357 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16381801 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21056836 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 38155373 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 5.37e-07 | 2 | 26 | 2 | 12074836 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30745454 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 5.37e-07 | 2 | 26 | 2 | 36717101 | |
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 5.37e-07 | 2 | 26 | 2 | 38395992 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 37820892 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 5.37e-07 | 2 | 26 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 5.37e-07 | 2 | 26 | 2 | 27743844 | |
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 5.37e-07 | 2 | 26 | 2 | 38928429 | |
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 5.37e-07 | 2 | 26 | 2 | 39251883 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 5.37e-07 | 2 | 26 | 2 | 26008989 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 37975162 | ||
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 5.37e-07 | 2 | 26 | 2 | 20813920 | |
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 5.37e-07 | 2 | 26 | 2 | 28636944 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 5.37e-07 | 2 | 26 | 2 | 32142647 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15050706 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 34464353 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25037583 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 23376566 | ||
| Pubmed | 7.43e-07 | 24 | 26 | 3 | 22534482 | ||
| Pubmed | Prox2 and Runx3 vagal sensory neurons regulate esophageal motility. | 1.34e-06 | 29 | 26 | 3 | 37192624 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 38124148 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 29466725 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 34825354 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 29521261 | ||
| Pubmed | PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. | 1.61e-06 | 3 | 26 | 2 | 30361375 | |
| Pubmed | Piezo1, a mechanically activated ion channel, is required for vascular development in mice. | 1.61e-06 | 3 | 26 | 2 | 24958852 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.61e-06 | 3 | 26 | 2 | 24394417 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.61e-06 | 3 | 26 | 2 | 29208674 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 37321223 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.61e-06 | 3 | 26 | 2 | 26507659 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 24022508 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 30726728 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 35650194 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 2.61e-06 | 130 | 26 | 4 | 19874574 | |
| Pubmed | 2.62e-06 | 300 | 26 | 5 | 19086053 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.07e-06 | 38 | 26 | 3 | 30786075 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 26283199 | ||
| Pubmed | Mechanosensory hair cells express two molecularly distinct mechanotransduction channels. | 3.22e-06 | 4 | 26 | 2 | 27893727 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 31253182 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 36563677 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 15728831 | ||
| Pubmed | Piezo mechanosensory channels regulate centrosome integrity and mitotic entry. | 3.22e-06 | 4 | 26 | 2 | 36574677 | |
| Pubmed | Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. | 3.22e-06 | 4 | 26 | 2 | 15001778 | |
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.22e-06 | 4 | 26 | 2 | 15953418 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 25660468 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16412217 | ||
| Pubmed | Composition of the GABA(A) receptors of retinal dopaminergic neurons. | 3.22e-06 | 4 | 26 | 2 | 10479684 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 3.22e-06 | 4 | 26 | 2 | 25483588 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 34852225 | ||
| Pubmed | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. | 5.37e-06 | 5 | 26 | 2 | 9039914 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 16787652 | ||
| Pubmed | Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. | 5.37e-06 | 5 | 26 | 2 | 36323321 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 10447508 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11331379 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 38442711 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 10328888 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 8.05e-06 | 6 | 26 | 2 | 10023064 | |
| Pubmed | Perivascular neurons instruct 3D vascular lattice formation via neurovascular contact. | 1.13e-05 | 7 | 26 | 2 | 38733989 | |
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 1.13e-05 | 7 | 26 | 2 | 10449790 | |
| Pubmed | The Piezo channel is a mechano-sensitive complex component in the mammalian inner ear hair cell. | 1.50e-05 | 8 | 26 | 2 | 38228630 | |
| Pubmed | Evidence for the involvement of ASIC3 in sensory mechanotransduction in proprioceptors. | 1.50e-05 | 8 | 26 | 2 | 27161260 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 28330839 | ||
| Pubmed | Piezo1 and Piezo2 collectively regulate jawbone development. | 1.50e-05 | 8 | 26 | 2 | 38619396 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 34112781 | ||
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 17698926 | ||
| Pubmed | 3.04e-05 | 81 | 26 | 3 | 22723691 | ||
| Pubmed | An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents. | 4.17e-05 | 13 | 26 | 2 | 32259485 | |
| Pubmed | 4.17e-05 | 13 | 26 | 2 | 17655760 | ||
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 22768092 | ||
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 21228161 | ||
| Pubmed | DRG afferents that mediate physiologic and pathologic mechanosensation from the distal colon. | 5.61e-05 | 15 | 26 | 2 | 37541195 | |
| Interaction | TMEM145 interactions | 1.47e-05 | 5 | 25 | 2 | int:TMEM145 | |
| Interaction | SSTR3 interactions | 1.06e-04 | 393 | 25 | 5 | int:SSTR3 | |
| Interaction | MCHR1 interactions | 1.14e-04 | 13 | 25 | 2 | int:MCHR1 | |
| Interaction | NALCN interactions | 1.33e-04 | 14 | 25 | 2 | int:NALCN | |
| Interaction | SCN11A interactions | 1.54e-04 | 15 | 25 | 2 | int:SCN11A | |
| Interaction | FAM241B interactions | 1.84e-04 | 90 | 25 | 3 | int:FAM241B | |
| Interaction | SCN9A interactions | 3.06e-04 | 21 | 25 | 2 | int:SCN9A | |
| Interaction | CACNB2 interactions | 3.68e-04 | 23 | 25 | 2 | int:CACNB2 | |
| Interaction | HHATL interactions | 4.01e-04 | 24 | 25 | 2 | int:HHATL | |
| Interaction | CACNA1D interactions | 4.01e-04 | 24 | 25 | 2 | int:CACNA1D | |
| Interaction | CACNB1 interactions | 4.36e-04 | 25 | 25 | 2 | int:CACNB1 | |
| Interaction | CACNB4 interactions | 4.36e-04 | 25 | 25 | 2 | int:CACNB4 | |
| Interaction | SCN1A interactions | 5.88e-04 | 29 | 25 | 2 | int:SCN1A | |
| Cytoband | 4p12 | 5.82e-05 | 20 | 26 | 2 | 4p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p12 | 9.94e-05 | 26 | 26 | 2 | chr4p12 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.29e-06 | 19 | 21 | 3 | 563 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.45e-06 | 26 | 21 | 3 | 253 | |
| GeneFamily | Solute carriers | 7.40e-05 | 395 | 21 | 5 | 752 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.02e-02 | 394 | 21 | 3 | 471 | |
| GeneFamily | EF-hand domain containing | 2.64e-02 | 219 | 21 | 2 | 863 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 3.33e-06 | 450 | 25 | 6 | M39072 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.77e-05 | 166 | 25 | 4 | M39026 | |
| Coexpression | GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP | 3.13e-05 | 192 | 25 | 4 | M4923 | |
| Coexpression | SOGA_COLORECTAL_CANCER_MYC_DN | 4.20e-05 | 71 | 25 | 3 | M45006 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | 1.08e-04 | 513 | 25 | 5 | M39069 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 1.76e-04 | 115 | 25 | 3 | M40201 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.98e-04 | 584 | 25 | 5 | M39068 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 162 | 26 | 4 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 167 | 26 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.69e-06 | 169 | 26 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.27e-05 | 107 | 26 | 3 | d4807f008619dfd3e215d602df0d02b135b1ac37 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.27e-05 | 107 | 26 | 3 | 3f24de1afbfd070f9db11c9acd02b90e5eb2511d | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.27e-05 | 107 | 26 | 3 | 5907b9632c88d48f293c3c6d37b7ef831fbcdd86 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.45e-05 | 127 | 26 | 3 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.97e-05 | 131 | 26 | 3 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.43e-05 | 141 | 26 | 3 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 8.07e-05 | 145 | 26 | 3 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 8.58e-05 | 148 | 26 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-05 | 155 | 26 | 3 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 159 | 26 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 163 | 26 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 164 | 26 | 3 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 26 | 3 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 26 | 3 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 26 | 3 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 166 | 26 | 3 | a907d39ca5cf023de633fe5f2b28759b7af4eebc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 167 | 26 | 3 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 167 | 26 | 3 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 167 | 26 | 3 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 167 | 26 | 3 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 167 | 26 | 3 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | severe_COVID-19-Neutrophil|World / disease group, cell group and cell class (v2) | 1.29e-04 | 170 | 26 | 3 | dfc807e0dd66179490a258ecbe8eb439e715799d | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 174 | 26 | 3 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.41e-04 | 175 | 26 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 175 | 26 | 3 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 175 | 26 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.41e-04 | 175 | 26 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 175 | 26 | 3 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.43e-04 | 176 | 26 | 3 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 26 | 3 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 26 | 3 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 178 | 26 | 3 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.51e-04 | 179 | 26 | 3 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 1.53e-04 | 180 | 26 | 3 | 44ba37bead1ac39bce4d3eef00961063c50ced0d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 181 | 26 | 3 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 181 | 26 | 3 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 181 | 26 | 3 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 26 | 3 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 1.79e-04 | 190 | 26 | 3 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | ILEUM-non-inflamed-(8)_Pericytes|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.97e-04 | 196 | 26 | 3 | b98fe1519e420d8b03c66e164bf4544f3dbb2e44 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 26 | 3 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-04 | 196 | 26 | 3 | c16fbd23d9e117831b55ab3da5b08b22dd972432 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.06e-04 | 199 | 26 | 3 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 2.06e-04 | 199 | 26 | 3 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 199 | 26 | 3 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.09e-04 | 200 | 26 | 3 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.68e-04 | 55 | 26 | 2 | 10e98fc862d89141512bdebae1231ef1a82105b0 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.68e-04 | 55 | 26 | 2 | a55d3edca2dd9ca7a703b2b3a5941b30b5f0a6df | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.68e-04 | 55 | 26 | 2 | bac333ea3914a49376105dd977a0b8493b0d2001 | |
| Computational | Genes in the cancer module 146. | 7.11e-06 | 102 | 14 | 4 | MODULE_146 | |
| Computational | Genes in the cancer module 288. | 1.33e-05 | 37 | 14 | 3 | MODULE_288 | |
| Computational | Membranal receptors. | 2.59e-05 | 517 | 14 | 6 | MODULE_64 | |
| Computational | Genes in the cancer module 173. | 1.87e-04 | 16 | 14 | 2 | MODULE_173 | |
| Computational | Genes in the cancer module 289. | 4.97e-04 | 124 | 14 | 3 | MODULE_289 | |
| Computational | Genes in the cancer module 27. | 9.00e-04 | 355 | 14 | 4 | MODULE_27 | |
| Drug | gabapentin | 6.40e-10 | 169 | 26 | 7 | CID000003446 | |
| Drug | morphine hydrochloride | GABRB1 GABRE CACNA1A GABRG1 CACNA1B CACNA1E CCR3 C5AR1 AGTR1 | 1.77e-09 | 481 | 26 | 9 | CID000004253 |
| Drug | AC 110 | 5.28e-09 | 4 | 26 | 3 | CID000022860 | |
| Drug | haloperidol | 8.91e-09 | 394 | 26 | 8 | CID000003559 | |
| Drug | eniluracil | 2.30e-08 | 27 | 26 | 4 | CID000043157 | |
| Drug | 3,4-dihydroquinazoline | 2.64e-08 | 6 | 26 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 2.64e-08 | 6 | 26 | 3 | CID000133976 | |
| Drug | riluzole | 3.71e-08 | 174 | 26 | 6 | CID000005070 | |
| Drug | APMPA | 4.61e-08 | 7 | 26 | 3 | CID000512300 | |
| Drug | 3-aminopropylphosphinic acid | 4.70e-08 | 32 | 26 | 4 | CID006335948 | |
| Drug | CGS 8216 | 5.34e-08 | 33 | 26 | 4 | CID000104916 | |
| Drug | fluspirilene | 6.05e-08 | 34 | 26 | 4 | CID000003396 | |
| Drug | baclofen | 6.45e-08 | 191 | 26 | 6 | CID000002284 | |
| Drug | atropine sulfate | 9.22e-08 | 347 | 26 | 7 | CID000003661 | |
| Drug | cyclothiazide | 1.05e-07 | 103 | 26 | 5 | CID000002910 | |
| Drug | AC1L1I54 | 1.31e-07 | 41 | 26 | 4 | CID000004426 | |
| Drug | guanethidine | 1.67e-07 | 113 | 26 | 5 | CID000003518 | |
| Drug | leys | 2.17e-07 | 11 | 26 | 3 | CID000484683 | |
| Drug | AC1L2VU3 | 2.89e-07 | 12 | 26 | 3 | CID000129572 | |
| Drug | tetradotoxin | 3.82e-07 | 428 | 26 | 7 | CID000020382 | |
| Drug | etorphine | 5.83e-07 | 59 | 26 | 4 | CID000026721 | |
| Drug | butamben | 5.96e-07 | 15 | 26 | 3 | CID000002482 | |
| Drug | pentasulfane | 7.33e-07 | 16 | 26 | 3 | CID000448216 | |
| Drug | lindane | 7.78e-07 | 154 | 26 | 5 | CID000000727 | |
| Drug | dopamine | 8.61e-07 | 715 | 26 | 8 | CID000000681 | |
| Drug | dihydroxyaflavinine | 8.89e-07 | 17 | 26 | 3 | CID000156857 | |
| Drug | AC1L2AC7 | 1.10e-06 | 69 | 26 | 4 | CID000068733 | |
| Drug | halothane | 1.20e-06 | 314 | 26 | 6 | CID000003562 | |
| Drug | norcepharadione B | 1.25e-06 | 2 | 26 | 2 | CID000189168 | |
| Drug | aristolactam AII | 1.25e-06 | 2 | 26 | 2 | CID000148657 | |
| Drug | alkosin | 1.25e-06 | 2 | 26 | 2 | CID005488638 | |
| Drug | piperolactam A | 1.25e-06 | 2 | 26 | 2 | CID003081016 | |
| Drug | N6-Me-dAdo | 1.27e-06 | 19 | 26 | 3 | CID000168948 | |
| Drug | pranidipine | 1.27e-06 | 19 | 26 | 3 | CID006436048 | |
| Drug | AC1L1KS5 | 1.71e-06 | 334 | 26 | 6 | CID000005631 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.89e-06 | 79 | 26 | 4 | CID005287890 | |
| Drug | LY320135 | 2.31e-06 | 23 | 26 | 3 | CID005311257 | |
| Drug | alpha-conotoxin SI | 2.31e-06 | 23 | 26 | 3 | CID000163979 | |
| Drug | capsazepine | 2.42e-06 | 84 | 26 | 4 | CID002733484 | |
| Drug | methohexital | 2.63e-06 | 24 | 26 | 3 | CID000009034 | |
| Drug | brimonidine | 2.66e-06 | 86 | 26 | 4 | CID000002435 | |
| Drug | hexachlorophene | 3.19e-06 | 90 | 26 | 4 | CID000003598 | |
| Drug | mAHP | 3.80e-06 | 27 | 26 | 3 | CID000220531 | |
| Drug | manidipine | 3.96e-06 | 95 | 26 | 4 | CID000004008 | |
| Drug | pentobarbital | 4.90e-06 | 224 | 26 | 5 | CID000004737 | |
| Drug | 3-isothujone | 5.26e-06 | 30 | 26 | 3 | CID000011027 | |
| Drug | AC1L1F6H | 6.13e-06 | 106 | 26 | 4 | CID000003104 | |
| Drug | N-methyl-DL-aspartic acid | 6.45e-06 | 655 | 26 | 7 | CID000004376 | |
| Drug | A61603 | 7.05e-06 | 33 | 26 | 3 | CID004038180 | |
| Drug | CNS 1145 | 7.05e-06 | 33 | 26 | 3 | CID000190902 | |
| Drug | AC1L2FYN | 7.05e-06 | 33 | 26 | 3 | CID000071333 | |
| Drug | IHC-64 | 7.05e-06 | 33 | 26 | 3 | CID000162753 | |
| Drug | methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate | 7.51e-06 | 4 | 26 | 2 | ctd:C034818 | |
| Drug | glutamate | 7.81e-06 | 962 | 26 | 8 | CID000000611 | |
| Drug | flurazepam | 8.44e-06 | 35 | 26 | 3 | CID000003393 | |
| Drug | 3-7a | 9.21e-06 | 36 | 26 | 3 | CID011987860 | |
| Drug | CP-80 | 9.21e-06 | 36 | 26 | 3 | CID000452640 | |
| Drug | secobarbital | 1.00e-05 | 37 | 26 | 3 | CID000005193 | |
| Drug | 8-cyclopentyltheophylline | 1.09e-05 | 38 | 26 | 3 | CID000001917 | |
| Drug | DMCM | 1.09e-05 | 38 | 26 | 3 | CID000104999 | |
| Drug | 3,4-diaminopyridine | 1.09e-05 | 38 | 26 | 3 | CID000005918 | |
| Drug | zaleplon | 1.18e-05 | 39 | 26 | 3 | CID000005719 | |
| Drug | amlodipine | 1.22e-05 | 126 | 26 | 4 | CID000002162 | |
| Drug | almagel | 1.25e-05 | 5 | 26 | 2 | CID003080942 | |
| Drug | S 8510 | 1.25e-05 | 5 | 26 | 2 | CID005488383 | |
| Drug | pimozide | 1.25e-05 | 127 | 26 | 4 | CID000016362 | |
| Drug | furosemide | 1.26e-05 | 272 | 26 | 5 | CID000003440 | |
| Drug | Gabrene | 1.27e-05 | 40 | 26 | 3 | CID005361323 | |
| Drug | gamma-aminobutyric acid | 1.27e-05 | 474 | 26 | 6 | CID000000119 | |
| Drug | clozapine | 1.30e-05 | 274 | 26 | 5 | CID000002818 | |
| Drug | BMY 7378 | 1.37e-05 | 41 | 26 | 3 | CID000002419 | |
| Drug | gaboxadol | 1.37e-05 | 41 | 26 | 3 | CID000003448 | |
| Drug | 5 beta-alphaxalone | 1.47e-05 | 42 | 26 | 3 | CID000068930 | |
| Drug | Fk 888 | 1.47e-05 | 42 | 26 | 3 | CID000107967 | |
| Drug | U46619 | 1.57e-05 | 285 | 26 | 5 | CID000005618 | |
| Drug | zolpidem | 1.58e-05 | 43 | 26 | 3 | CID000005732 | |
| Drug | Calcium | 1.59e-05 | 493 | 26 | 6 | ctd:D002118 | |
| Drug | lorazepam | 1.70e-05 | 44 | 26 | 3 | CID000003958 | |
| Drug | heptachlor epoxide | 1.94e-05 | 46 | 26 | 3 | CID000013930 | |
| Drug | thymol | 1.94e-05 | 46 | 26 | 3 | CID000006989 | |
| Drug | nimodipine | 2.12e-05 | 145 | 26 | 4 | CID000004497 | |
| Drug | nicardipine | 2.12e-05 | 145 | 26 | 4 | CID000004473 | |
| Drug | AC1Q5UBL | 2.17e-05 | 146 | 26 | 4 | CID000005466 | |
| Drug | vigabatrin | 2.35e-05 | 49 | 26 | 3 | CID000005665 | |
| Drug | KW-3049 | 2.50e-05 | 50 | 26 | 3 | CID000002324 | |
| Drug | procaine | 2.61e-05 | 153 | 26 | 4 | CID000004914 | |
| Drug | procymidone | 2.75e-05 | 155 | 26 | 4 | ctd:C035988 | |
| Drug | BAPTA | 2.91e-05 | 324 | 26 | 5 | CID000104751 | |
| Drug | triazolam | 3.15e-05 | 54 | 26 | 3 | CID000005556 | |
| Drug | Cinildipine | 3.52e-05 | 56 | 26 | 3 | CID000002752 | |
| Drug | nefiracetam | 3.52e-05 | 56 | 26 | 3 | CID000071157 | |
| Drug | felodipine | 3.86e-05 | 169 | 26 | 4 | CID000003333 | |
| Drug | flunitrazepam | 4.12e-05 | 59 | 26 | 3 | CID000003380 | |
| Drug | 5 beta-pregnanediol | 4.33e-05 | 60 | 26 | 3 | CID000012547 | |
| Drug | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 4.33e-05 | 60 | 26 | 3 | ctd:C060229 | |
| Drug | nilvadipine | 4.33e-05 | 60 | 26 | 3 | CID000004494 | |
| Drug | GTP[S] | 4.41e-05 | 591 | 26 | 6 | CID000001764 | |
| Drug | IAA-94 | 4.55e-05 | 61 | 26 | 3 | CID000003667 | |
| Drug | gamma-Aminobutyric Acid | 4.78e-05 | 62 | 26 | 3 | ctd:D005680 | |
| Drug | EGTA-AM | 4.78e-05 | 62 | 26 | 3 | CID000121907 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.37e-10 | 3 | 25 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.15e-09 | 4 | 25 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.88e-08 | 7 | 25 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 2.36e-06 | 477 | 25 | 6 | C0005586 | |
| Disease | rhinitis (is_marker_for) | 7.96e-06 | 46 | 25 | 3 | DOID:4483 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 3.48e-04 | 163 | 25 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | Mood Disorders | 3.80e-04 | 168 | 25 | 3 | C0525045 | |
| Disease | asthma (implicated_via_orthology) | 4.03e-04 | 35 | 25 | 2 | DOID:2841 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 5.44e-04 | 190 | 25 | 3 | C0020538 | |
| Disease | multiple sclerosis (is_marker_for) | 7.91e-04 | 49 | 25 | 2 | DOID:2377 (is_marker_for) | |
| Disease | Mental Depression | 1.26e-03 | 254 | 25 | 3 | C0011570 | |
| Disease | Alcoholic Intoxication, Chronic | 1.47e-03 | 268 | 25 | 3 | C0001973 | |
| Disease | juvenile idiopathic arthritis | 1.79e-03 | 74 | 25 | 2 | EFO_0002609 | |
| Disease | Depressive disorder | 1.82e-03 | 289 | 25 | 3 | C0011581 | |
| Disease | beverage consumption measurement | 2.25e-03 | 83 | 25 | 2 | EFO_0010088 | |
| Disease | Dystonia | 2.41e-03 | 86 | 25 | 2 | C0013421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVYFVVFPFFFVNIF | 1491 | O00555 | |
| YFVVFPFFFVNIFVA | 1406 | Q15878 | |
| VLFFFFSWIPHQIFT | 246 | P30556 | |
| AVVASFFIFWLPYQV | 246 | P21730 | |
| FFSVFAVPWFEQYKI | 116 | Q9H112 | |
| YVVYFVVFPFFFVNI | 1396 | Q00975 | |
| FFFIFYSQIWILYPI | 261 | A6NMU1 | |
| FNYFVVTNFFWMFVE | 191 | Q13324 | |
| FFPITFSLFNVVYWL | 456 | P18505 | |
| VVFPVTFFFFNVLYW | 486 | P78334 | |
| SWPKTVYFTFQFYRF | 661 | O75161 | |
| AVFFIFWTPYNVAIL | 246 | P51677 | |
| PVVFWISGFYFTQSF | 3961 | Q8TD57 | |
| FFPTAFALFNLVYWV | 446 | Q8N1C3 | |
| WFTLYQFFLAFALPF | 276 | Q99705 | |
| FQPFWTFFALVLFWV | 336 | Q8WWI5 | |
| APFFAFFIYSWFFIE | 256 | Q4U2R8 | |
| FWALFAYSSFVIPFI | 321 | Q7RTX9 | |
| SFIFFAKPFTFQYVW | 341 | Q9H1N7 | |
| FFIPEGTFTTVWFYV | 141 | Q9NRX5 | |
| GVFVVCWFPFFFTYT | 396 | P08913 | |
| IVVKYFFQFGFFPWN | 1976 | Q9H5I5 | |
| YFWLQDFVPTSVFFL | 286 | Q9Y2D2 | |
| VVVKYLFQFGFFPWN | 1741 | Q92508 | |
| YYVAFFTSPFVVFSW | 726 | Q7Z2W7 | |
| FTSPFVVFSWNVVFY | 731 | Q7Z2W7 | |
| PFYVPFFAAYTLWFF | 346 | Q8NBT3 |